For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Placebo | Placebo once daily for 7 days | None | None | 0 | 22 | 11 | 22 | View |
| ER Niacin/Laropiprant | Extended Release (ER) Niacin 2 g/Laropiprant 40 mg once daily for 7 days | None | None | 0 | 23 | 17 | 23 | View |
| ER Niacin | ER Niacin 2 g once daily for 7 days | None | None | 1 | 25 | 23 | 25 | View |
| Laropiprant | Laropiprant 40 mg once daily for 7 days | None | None | 0 | 23 | 12 | 23 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal Discomfort | None | Gastrointestinal disorders | MedDRA (10.1) | View |
| Abdominal Distension | None | Gastrointestinal disorders | MedDRA (10.1) | View |
| Abdominal Pain | None | Gastrointestinal disorders | MedDRA (10.1) | View |
| Abdominal Pain Upper | None | Gastrointestinal disorders | MedDRA (10.1) | View |
| Constipation | None | Gastrointestinal disorders | MedDRA (10.1) | View |
| Diarrhoea | None | Gastrointestinal disorders | MedDRA (10.1) | View |
| Dyspepsia | None | Gastrointestinal disorders | MedDRA (10.1) | View |
| Nausea | None | Gastrointestinal disorders | MedDRA (10.1) | View |
| Vomiting | None | Gastrointestinal disorders | MedDRA (10.1) | View |
| Asthenia | None | General disorders | MedDRA (10.1) | View |
| Feeling Hot | None | General disorders | MedDRA (10.1) | View |
| Hypoglycaemia | None | Metabolism and nutrition disorders | MedDRA (10.1) | View |
| Back Pain | None | Musculoskeletal and connective tissue disorders | MedDRA (10.1) | View |
| Burning Sensation | None | Nervous system disorders | MedDRA (10.1) | View |
| Dizziness | None | Nervous system disorders | MedDRA (10.1) | View |
| Headache | None | Nervous system disorders | MedDRA (10.1) | View |
| Paraesthesia | None | Nervous system disorders | MedDRA (10.1) | View |
| Erythema | None | Skin and subcutaneous tissue disorders | MedDRA (10.1) | View |
| Pruritus | None | Skin and subcutaneous tissue disorders | MedDRA (10.1) | View |
| Flushing | None | Vascular disorders | MedDRA (10.1) | View |